The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia

A 17‐gene stemness (LSC17) score determines risk in acute myeloid leukaemia patients treated with standard chemotherapy regimens. The present study further analysed the impact of the LSC17 score at diagnosis on outcomes following allogeneic haematopoietic cell transplantation (HCT). Out of 452 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dennis D. H., Novitzky Basso, Igor, Kim, Taehyung Simon, Yi, Seong Yoon, Kim, Kyoung Ha, Murphy, Tracy, Chan, Steven, Minden, Mark, Pasic, Ivan, Lam, Wilson, Law, Arjun, Michelis, Fotios V., Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey, Kumar, Rajat, Ng, Stanley W. K., Stockley, Tracy, Zhang, Tong, King, Ian, Mattsson, Jonas, Wang, Jean C. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Cell Therapy/Stem Cell Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422016/
https://www.ncbi.nlm.nih.gov/pubmed/36051057
http://dx.doi.org/10.1002/jha2.466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422016/
https://www.ncbi.nlm.nih.gov/pubmed/36051057
http://dx.doi.org/10.1002/jha2.466

Ejemplares similares